CORRECT (Feb 27): Glaxo Says Filing For Asthma Treatment Accepted Read More
EXECUTIVE CHANGE SUMMARY: Glaxo Taps Former Bristol Myers Squibb CFO Read More
GlaxoSmithKline Notes Positive HIV Study Results, Partnership Renewal Read More
Glaxo Says Trelegy Ellipta Filing For Asthma Treatment Accepted By EMA Read More
GlaxoSmithKline's New Drug Application For Zejula Accepted By US FDA Read More
TOP NEWS: GlaxoSmithKline And Clover Team Up On Coronavirus Vaccine Read More
LONDON MARKET MIDDAY: Smith & Nephew, Lloyds, BAE Rise But FTSE Muted Read More
UK WINNERS & LOSERS SUMMARY: Moneysupermarket Shines After Strong 2019 Read More
LONDON MARKET OPEN: FTSE Edges Up As Smith & Nephew And Lloyds Gain Read More
UK BROKER RATINGS SUMMARY: JPMorgan Upgrades Severn Trent To Neutral Read More
UK Dividends Calendar - Next 7 Days Read More
UK BROKER RATINGS SUMMARY: Berenberg Cuts Croda Cut To Hold From Buy Read More
UK BROKER RATINGS SUMMARY: Goldman Cuts Whitbread To Sell From Neutral Read More
UK BROKER RATINGS SUMMARY: Goldman Adds HSBC, Pulls Melrose From List Read More
UK BROKER RATINGS SUMMARY: Investec Double Downgrades Tate To Sell Read More
UPDATE: GlaxoSmithKline To Axe Over 700 Jobs In Belgium Read More
TOP NEWS: New Pfizer Joint Venture Boosts GlaxoSmithKline 2019 Profit Read More
Profits At UK-Listed Businesses Falls For Second Consecutive Quarter Read More
UK BROKER RATINGS SUMMARY: HSBC Downgrades BT To Hold From Buy Read More
MITIE Revenue Grows In First Nine Months But Flat On Organic Basis Read More
